72-year-old Michel Polnareff had to interrupt his tour due to a double pulmonary embolism. Its vital prognosis is better, but remains committed.
“He could have died on stage. He was hot ”. Michel Polnareff was admitted on December 3 to the American hospital in Neuilly-Sur-Seine for bilateral pulmonary embolism, a serious pathology that is life-threatening. “It is the characteristic of this disease, explained Dr. Philippe Siou to the Parisian Monday evening. But we were able to diagnose it pretty quickly. I am giving myself 48 hours to decide. In the meantime, he remains of course hospitalized with us. “
His hospitalization follows an intense six-month tour, during which Michel Polnareff had done about fifty concerts. It came to end a complicated week for the 72-year-old singer. He had to cancel his two concerts in Paris on Friday, and in Nantes on Saturday.
“Michel suffered from sinusitis at the beginning of the week, which turned to bronchitis, then specified his press secretary to AFP. He suffered infiltrations to be able to hold the scene in Toulouse, Pau and Bordeaux. But on Friday morning, he was seized with severe dizziness and a drop in blood pressure ”.
Immobilization
A pulmonary embolism is a partial or total obstruction of the pulmonary artery, which takes blood from the heart to the lungs for re-oxygenation. When the embolism is bilateral, as for the singer of Marilou, it means that both lungs are affected. The obstruction comes from a clot formed elsewhere, often in the legs (a phlebitis), which travels in the bloodstream, and blocks the artery where it narrows, as it approaches the lungs.
It is manifested by chest pain and difficulty in breathing, which often occurs after immobilization, causing blood flow to slow down. Typically after surgery, or even after a long plane ride. For example, the risk of embolism is six times higher in people under the age of 60 who watch television for at least 5 hours a day, compared to those who only watch it for two hours. Cardiac pathologies can also favor its appearance.
Michel Polnareff is currently on antithrombolitics and anticoagulants, a treatment that dissolves the clot and prevents new ones from forming. This process takes time, and that is why doctors are refusing to comment until Wednesday.
Each year, around 100,000 people are said to be affected by pulmonary embolism in France. 10 to 20% of them do not survive.
.